Healthcare & Medical Investment Corporation (TYO:3455)
91,500
+100 (0.11%)
At close: Oct 9, 2026
TYO:3455 Cash Flow Statement
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Net Income | 2,075 | 2,076 | 2,081 | 2,119 | 2,380 | 1,835 |
Depreciation & Amortization | 1,245 | 1,222 | 1,188 | 1,127 | 1,116 | 968 |
Other Amortization | 2.41 | 2.41 | 7.11 | 13.89 | 13.89 | - |
Change in Accounts Receivable | -4.92 | 0.27 | 1.67 | 0.8 | -48.97 | -3 |
Change in Accounts Payable | -1.33 | 6.47 | -1.96 | 8.1 | -6.51 | 20 |
Change in Other Net Operating Assets | 50.18 | -18.97 | -25.98 | -101.3 | 1,428 | - |
Other Operating Activities | 134.66 | 131.12 | 128.09 | 119.84 | 115.51 | 123 |
Operating Cash Flow | 3,501 | 3,420 | 3,379 | 3,287 | 4,998 | 2,943 |
Operating Cash Flow Growth | 6.43% | 1.23% | 2.78% | -34.22% | 69.81% | 5.37% |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Acquisition of Real Estate Assets | -4,521 | -4,411 | -4,230 | -391.11 | -14,592 | -980 |
Net Sale / Acq. of Real Estate Assets | -4,521 | -4,411 | -4,230 | -391.11 | -14,592 | -980 |
Investment in Marketable & Equity Securities | 7.09 | -92.96 | -101.16 | - | - | - |
Other Investing Activities | 187.89 | 187.52 | 48.6 | - | 151.82 | 60 |
Investing Cash Flow | -4,326 | -4,317 | -4,283 | -391.11 | -14,443 | -920 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Short-Term Debt Issued | - | 1,970 | 1,170 | 2,000 | 2,500 | - |
Long-Term Debt Issued | - | 9,350 | 10,050 | 7,250 | 13,250 | - |
Total Debt Issued | 11,320 | 11,320 | 11,220 | 9,250 | 15,750 | - |
Short-Term Debt Repaid | - | -1,170 | -2,000 | -2,000 | -500 | - |
Long-Term Debt Repaid | - | -6,400 | -5,550 | -7,250 | -9,250 | - |
Total Debt Repaid | -7,570 | -7,570 | -7,550 | -9,250 | -9,750 | - |
Net Debt Issued (Repaid) | 3,750 | 3,750 | 3,670 | - | 6,000 | - |
Common Dividends Paid | -2,318 | -2,282 | -2,335 | -2,457 | -2,217 | -2,018 |
Other Financing Activities | -138.27 | -138.46 | -189.77 | -108.63 | 5,523 | -105 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | -0 | 0 | -1 |
Net Cash Flow | 469.35 | 432.55 | 240.98 | 330.12 | -140.42 | -101 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Levered Free Cash Flow | 2,552 | 2,527 | 2,560 | 2,427 | 2,729 | 1,241 |
Unlevered Free Cash Flow | 2,854 | 2,795 | 2,780 | 2,598 | 2,860 | 1,428 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Cash Interest Paid | 629.77 | 575.61 | 351.14 | 275.54 | 210.74 | 190 |
Cash Income Tax Paid | 2.66 | 2.69 | 1.84 | 1.57 | 1.78 | - |
Change in Working Capital | 43.94 | -12.24 | -26.28 | -92.41 | 1,372 | 17 |